Nephro Care India share news, announcements and annual reports

NSE: NEPHROCAREHealthcare Services

Nephro Care India Limited · Face value ₹10 · Listed Jul 2024 · Issue price ₹90

₹80.75₹0.40 (0.49%)

Share price at the NSE close on 28 Oct 2026. Previous close ₹81.15.

28 Oct: open ₹80.00, high ₹81.75, low ₹80.00

52-week range of traded prices to 28 Oct 2026

₹50.05Low, 30 Mar 2026₹156.35High, 18 Nov 2025

Market cap: ₹133 Cr
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, NSE: 4,40072.7% delivered

Nephro Care India disputes and clarifications

13 filed, newest first.

Sep 2026
- 1 Sep · Legal
  Exchange had sought clarification from Nephro Care India Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Aug 2026
- 28 Aug · Legal
  Exchange has sought clarification from Nephro Care India Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Jul 2026
- 9 Jul · Legal
  Exchange had sought clarification from Nephro Care India Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Half Yearly figures not submitted by the Company The response of the Company is enclosed.
Jun 2026
- 23 Jun · Legal
  Exchange has sought clarification from Nephro Care India Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Half Yearly figures not submitted by the Company The response of the Company is awaited.
Apr 2026
- 9 Apr · Legal
  Significant movement in price has been observed in Nephro Care India Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Mar 2026
- 6 Mar · Legal
  Exchange had sought clarification from Nephro Care India Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is enclosed.
- 5 Mar · Legal
  Exchange has sought clarification from Nephro Care India Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is awaited.
Feb 2025
- 24 Feb · Legal
  Significant movement in price has been observed in Nephro Care India Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Nephro Care India Limited has submitted their response.
- 13 Feb · Legal
  Significant movement in price has been observed in Nephro Care India Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Dec 2024
- 20 Dec · Legal
  Exchange had sought clarification from Nephro Care India Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
- 13 Dec · Legal
  Exchange has sought clarification from Nephro Care India Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Sep 2024
- 16 Sep · Legal
  Exchange had sought clarification from Nephro Care India Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is enclosed.
- 6 Sep · Legal
  Exchange has sought clarification from Nephro Care India Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.

Nephro Care India disputes and clarifications

Sep 2026

Aug 2026

Jul 2026

Jun 2026

Apr 2026

Mar 2026

Feb 2025

Dec 2024

Sep 2024